Genetics References Clinical studies Fra(X)(p22) not associated with infantile autism. Lancet 1984; 2

:)


Download 0.6 Mb.
Page2/12
Date conversion29.03.2017
Size0.6 Mb.
1   2   3   4   5   6   7   8   9   ...   12
1(2): 108-113.

115. Brune CW, Kim SJ, Salt J, Leventhal BL, Lord C, Cook EH, Jr. 5-HTTLPR Genotype-Specific Phenotype in Children and Adolescents With Autism. Am J Psychiatry 2006; 163(12): 2148-2156.
116. Brune CW, Korvatska E, Allen-Brady K, Cook EH, Jr., Dawson G, Devlin B et al. Heterogeneous association between engrailed-2 and autism in the CPEA network. Am J Med Genet B Neuropsychiatr Genet 2008; 147B(2): 187-193.
117. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009; 5(6): e1000536.
118. Budimirovic DB, Bukelis I, Cox C, Gray RM, Tierney E, Kaufmann WE. Autism spectrum disorder in Fragile X syndrome: differential contribution of adaptive socialization and social withdrawal. Am J Med Genet A 2006; 140A(17): 1814-1826.

119. Buizer-Voskamp JE, Franke L, Staal WG, van Daalen E, Kemner C, Ophoff RA et al. Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism. Eur J Hum Genet 2010; 18(5): 588-595.

120. Bukelis I, Porter FD, Zimmerman AW, Tierney E. Smith-Lemli-Opitz syndrome and autism spectrum disorder. Am J Psychiatry 2007; 164(11): 1655-1661.
121. Bundey S, Hardy C, Vickers S, Kilpatrick MW, Corbett JA. Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol 1994; 36(8): 736-742.
122. Burd L, Kerbeshian J. Familial pervasive development disorder, Tourette disorder and hyperlexia. Neurosci Biobehav Rev 1988; 12(3-4): 233-234.
123. Burd L, Kerbeshinn J, Fisher W, Martsolf JT. A case of autism and mosaic of trisomy 8. J Autism Dev Disord 1985; 15(3): 351-352.
124. Burd L, Martsolf JT, Kerbeshian J, Jalal SM. Partial 6p trisomy associated with infantile autism. Clin Genet 1988; 33(5): 356-359.
125. Burusnukul P, de Los Reyes EC, Yinger J, Boue DR. Danon disease: an unusual presentation of autism. Pediatr Neurol 2008; 39(1): 52-54.

126. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 2005; 42(4): 318-321.

127. Buttenschon HN, Lauritsen MB, El Daoud A, Hollegaard M, Jorgensen M, Tvedegaard K et al. A population-based association study of glutamate decarboxylase 1 as a candidate gene for autism. J Neural Transm 2009; 116(3): 381-388.
128. Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J et al. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(4): 484-491.
129. Buxbaum JD, Cai G, Nygren G, Chaste P, Delorme R, Goldsmith J et al. Mutation analysis of the NSD1 gene in patients with autism spectrum disorders and macrocephaly. BMC Med Genet 2007; 8: 68.
130. Buxbaum JD, Silverman J, Keddache M, Smith CJ, Hollander E, Ramoz N et al. Linkage analysis for autism in a subset families with obsessive-compulsive behaviors: evidence for an autism susceptibility gene on chromosome 1 and further support for susceptibility genes on chromosome 6 and 19. Mol Psychiatry 2004; 9(2): 144-150.

131. Buxbaum JD, Silverman JM, Smith CJ, Greenberg DA, Kilifarski M, Reichert J et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 2002; 7(3): 311-316.

132. Buxbaum JD, Silverman JM, Smith CJ, Kilifarski M, Reichert J, Hollander E et al. Evidence for a susceptibility gene for autism on chromosome 2 and for genetic heterogeneity. Am J Hum Genet 2001; 68(6): 1514-1520.
133. Buyske S, Williams TA, Mars AE, Stenroos ES, Ming SX, Wang R et al. Analysis of case-parent trios at a locus with a deletion allele: association of GSTM1 with autism. BMC Genet 2006; 7: 8.
134. Caglayan AO, Gumus H. Autism with del15p.11.1: case report with a new cytogenetic finding. Genet Couns 2010; 21(2): 199-204.
135. Cai G, Edelmann L, Goldsmith JE, Cohen N, Nakamine A, Reichert JG et al. Multiplex ligation-dependent probe amplification for genetic screening in autism spectrum disorders: efficient identification of known microduplications and identification of a novel microduplication in ASMT. BMC Med Genomics 2008; 1: 50.
136. Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM et al. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 2009; 123(3): 1018-1024.

137. Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P et al. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol 2007; 62(3): 243-250.

138. Campbell DB, Li C, Sutcliffe JS, Persico AM, Levitt P. Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res 2008; 1(3): 159-168.
139. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S et al. A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci U S A 2006; 103(45): 16834-16839.
140. Campbell DB, Warren D, Sutcliffe JS, Lee EB, Levitt P. Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 2010; 153B(2): 438-446.
141. Cannon DS, Miller JS, Robison RJ, Villalobos ME, Wahmhoff NK, Allen-Brady K et al. Genome-wide linkage analyses of two repetitive behavior phenotypes in Utah pedigrees with autism spectrum disorders. Mol Autism 2010; 1(1): 3.
142. Cantor RM, Kono N, Duvall JA, Alvarez-Retuerto A, Stone JL, Alarcon M et al. Replication of autism linkage: fine-mapping peak at 17q21. Am J Hum Genet 2005; 76(6): 1050-1056.

143. Cantu ES, Stone JW, Wing AA, Langee HR, Williams CA. Cytogenetic survey for autistic fragile X carriers in a mental retardation center. Am J Ment Retard 1990; 94(4): 442-447.

144. Carayol J, Schellenberg GD, Tores F, Hager J, Ziegler A, Dawson G. Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk. Mol Autism 2010; 1(1): 4.
145. Carmona-Mora P, Walz K. Retinoic Acid Induced 1, RAI1: A Dosage Sensitive Gene Related to Neurobehavioral Alterations Including Autistic Behavior. Curr Genomics 2010; 11(8): 607-617.
146. Carney RM, Wolpert CM, Ravan SA, Shahbazian M, Ashley-Koch A, Cuccaro ML et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 2003; 28(3): 205-211.
147. Carratala F, Galan F, Moya M, Estivill X, Pritchard MA, Llevadot R et al. A patient with autistic disorder and a 20/22 chromosomal translocation. Dev Med Child Neurol 1998; 40(7): 492-495.
148. Carreira IM, Melo JB, Rodrigues C, Backx L, Vermeesch J, Weise A et al. Molecular cytogenetic characterisation of a mosaic add(12)(p13.3) with an inv dup(3)(q26.31 --> qter) detected in an autistic boy. Mol Cytogenet 2009; 2: 16.

149. Carter M, Nikkel S, Fernandez B, Marshall C, Noor A, Lionel A et al. Hemizygous deletions on chromosome 1p21.3 involving the DPYD gene in individuals with autism spectrum disorder. Clin Genet 2010.

150. Castermans D, Thienpont B, Volders K, Crepel A, Vermeesch JR, Schrander-Stumpel CT et al. Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism. Eur J Hum Genet 2008; 16(10): 1187-1192.
151. Castermans D, Vermeesch JR, Fryns JP, Steyaert JG, Van de Ven WJ, Creemers JW et al. Identification and characterization of the TRIP8 and REEP3 genes on chromosome 10q21.3 as novel candidate genes for autism. Eur J Hum Genet 2007; 15(4): 422-431.
152. Castermans D, Wilquet V, Parthoens E, Huysmans C, Steyaert J, Swinnen L et al. The neurobeachin gene is disrupted by a translocation in a patient with idiopathic autism. J Med Genet 2003; 40(5): 352-356.
153. Chagnon YC. Shared chromosomal susceptibility regions between autism and other mental disorders. Int Rev Neurobiol 2005; 71: 419-443.
154. Chagnon YC. Shared susceptibility region on chromosome 15 between autism and catatonia. Int Rev Neurobiol 2006; 72: 165-178.

155. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009; 2(3): 157-177.

156. Challman TD, Barbaresi WJ, Katusic SK, Weaver A. The yield of the medical evaluation of children with pervasive developmental disorders. J Autism Dev Disord 2003; 33(2): 187-192.
157. Chaste P, Clement N, Mercati O, Guillaume JL, Delorme R, Botros HG et al. Identification of pathway-biased and deleterious melatonin receptor mutants in autism spectrum disorders and in the general population. PLoS One 2010; 5(7): e11495.
158. Chaste P, Nygren G, Anckarsater H, Rastam M, Coleman M, Leboyer M et al. Mutation screening of the ARX gene in patients with autism. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(2): 228-230.
159. Chen CP, Lin SP, Chern SR, Chen YJ, Tsai FJ, Wu PC et al. Array-CGH detection of a de novo 2.8 Mb deletion in 2q24.2-->q24.3 in a girl with autistic features and developmental delay. Eur J Med Genet 2010; 53(4): 217-220.
160. Chen CP, Lin SP, Chern SR, Tsai FJ, Wu PC, Lee CC et al. A de novo 7.9 Mb deletion in 22q13.2-->qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings. Eur J Med Genet 2010; 53(5): 329-332.

161. Chen GK, Kono N, Geschwind DH, Cantor RM. Quantitative trait locus analysis of nonverbal communication in autism spectrum disorder. Mol Psychiatry 2006; 11(2): 214-220.

162. Cheng L, Ge Q, Sun B, Yu P, Ke X, Lu Z. Polyacrylamide gel-based microarray: a novel method applied to the association Study between the polymorphisms of BDNF gene and autism. J Biomed Nanotechnol 2009; 5(5): 542-550.
163. Cheng L, Ge Q, Xiao P, Sun B, Ke X, Bai Y et al. Association study between BDNF gene polymorphisms and autism by three-dimensional gel-based microarray. Int J Mol Sci 2009; 10(6): 2487-2500.
164. Cheslack-Postava K, Fallin MD, Avramopoulos D, Connors SL, Zimmerman AW, Eberhart CG et al. beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol Psychiatry 2007; 12(3): 283-291.
165. Cheung J, Petek E, Nakabayashi K, Tsui LC, Vincent JB, Scherer SW. Identification of the human cortactin-binding protein-2 gene from the autism candidate region at 7q31. Genomics 2001; 78(1-2): 7-11.
166. Chien WH, Gau SS, Wu YY, Huang YS, Fang JS, Chen YJ et al. Identification and molecular characterization of two novel chromosomal deletions associated with autism. Clin Genet 2010; 78(5): 449-456.

167. Chien WH, Wu YY, Gau SS, Huang YS, Soong WT, Chiu YN et al. Association study of the SLC25A12 gene and autism in Han Chinese in Taiwan. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(1): 189-192.

168. Cho IH, Yoo HJ, Park M, Lee YS, Kim SA. Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res 2007; 1139: 34-41.
169. Cho SC, Yim SH, Yoo HK, Kim MY, Jung GY, Shin GW et al. Copy number variations associated with idiopathic autism identified by whole-genome microarray-based comparative genomic hybridization. Psychiatr Genet 2009; 19(4): 177-185.
170. Chodirker BN, Chudley AE. Routine genetic testing for Asperger syndrome. Genet Med 2008; 10(11): 843-845; author reply 845.
171. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S et al. Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 2008; 63(12): 1111-1117.
172. Chubykin AA, Liu X, Comoletti D, Tsigelny I, Taylor P, Sudhof TC. Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem 2005; 280(23): 22365-22374.

173. Chudley AE, Gutierrez E, Jocelyn LJ, Chodirker BN. Outcomes of genetic evaluation in children with pervasive developmental disorder. J Dev Behav Pediatr 1998; 19(5): 321-325.

174. Chung S, Hong JP, Yoo HK. Association of the DAO and DAOA gene polymorphisms with autism spectrum disorders in boys in Korea: a preliminary study. Psychiatry Res 2007; 153(2): 179-182.
175. Clifford S, Dissanayake C, Bui QM, Huggins R, Taylor AK, Loesch DZ. Autism spectrum phenotype in males and females with fragile X full mutation and premutation. J Autism Dev Disord 2007; 37(4): 738-747.
176. Cochrane LE, Tansey KE, Gill M, Gallagher L, Anney RJ. Lack of association between markers in the ITGA3, ITGAV, ITGA6 and ITGB3 and autism in an Irish sample. Autism Res 2010; 3(6): 342-344.
177. Cohen IL, Brown WT, Jenkins EC, Krawczun MS, French JH, Raguthu S et al. Fragile X syndrome in females with autism. Am J Med Genet 1989; 34(2): 302-303.
178. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, Brown WT et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin Genet 2003; 64(3): 190-197.
179. Collins AL, Ma D, Whitehead PL, Martin ER, Wright HH, Abramson RK et al. Investigation of autism and GABA receptor subunit genes in multiple ethnic groups. Neurogenetics 2006; 7(3): 167-174.

180. Collins JS, Schroer RJ, Bird J, Michaelis RC. The HOXA1 A218G polymorphism and autism: lack of association in white and black patients from the South Carolina Autism Project. J Autism Dev Disord 2003; 33(3): 343-348.

181. Combi R, Redaelli S, Beghi M, Clerici M, Cornaggia CM, Dalpra L. Clinical and genetic evaluation of a family showing both autism and epilepsy. Brain Res Bull 2010; 82(1-2): 25-28.
182. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266(13): 1793-1800.
183. Comings DE, Gade R, Muhleman D, Sverd J. No association of a tyrosine hydroxylase gene tetranucleotide repeat polymorphism in autism, Tourette syndrome, or ADHD. Biol Psychiatry 1995; 37(7): 484-486.
184. Comoletti D, De Jaco A, Jennings LL, Flynn RE, Gaietta G, Tsigelny I et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 2004; 24(20): 4889-4893.
185. Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C et al. Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry 2004; 55(4): 413-419.

186. Connolly BS, Feigenbaum AS, Robinson BH, Dipchand AI, Simon DK, Tarnopolsky MA. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochem Biophys Res Commun 2010; 402(2): 443-447.

187. Connors SL, Crowell DE, Eberhart CG, Copeland J, Newschaffer CJ, Spence SJ et al. beta2-adrenergic receptor activation and genetic polymorphisms in autism: data from dizygotic twins. J Child Neurol 2005; 20(11): 876-884.
188. Conroy J, Cochrane L, Anney RJ, Sutcliffe JS, Carthy P, Dunlop A et al. Fine mapping and association studies in a candidate region for autism on chromosome 2q31-q32. Am J Med Genet B Neuropsychiatr Genet 2009; 150B(4): 535-544.
189. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 2004; 9(6): 587-593.
190. Cook EH, Jr., Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2(3): 247-250.
191. Cook EH, Jr., Courchesne RY, Cox NJ, Lord C, Gonen D, Guter SJ et al. Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers. Am J Hum Genet 1998; 62(5): 1077-1083.

192. Cook EH, Jr., Lindgren V, Leventhal BL, Courchesne R, Lincoln A, Shulman C et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 1997; 60(4): 928-934.

193. Coon H, Dunn D, Lainhart J, Miller J, Hamil C, Battaglia A et al. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet 2005; 135B(1): 42-46.
194. Coon H, Matsunami N, Stevens J, Miller J, Pingree C, Camp NJ et al. Evidence for linkage on chromosome 3q25-27 in a large autism extended pedigree. Hum Hered 2005; 60(4): 220-226.
195. Coon H, Villalobos ME, Robison RJ, Camp NJ, Cannon DS, Allen-Brady K et al. Genome-wide linkage using the Social Responsiveness Scale in Utah autism pedigrees. Mol Autism 2010; 1(1): 8.
196. Correia C, Coutinho AM, Almeida J, Lontro R, Lobo C, Miguel TS et al. Association of the alpha4 integrin subunit gene (ITGA4) with autism. Am J Med Genet B Neuropsychiatr Genet 2009; 150B(8): 1147-1151.
197. Correia C, Coutinho AM, Diogo L, Grazina M, Marques C, Miguel T et al. Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord 2006; 36(8): 1137-1140.

198. Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS et al. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. Pharmacogenomics J 2010; 10(5): 418-430.

199. Correia CT, Coutinho AM, Sequeira AF, Sousa IG, Lourenco Venda L, Almeida JP et al. Increased BDNF levels and NTRK2 gene association suggest a disruption of BDNF/TrkB signaling in autism. Genes Brain Behav 2010; 9(7): 841-848.
200. Coutinho AM, Oliveira G, Katz C, Feng J, Yan J, Yang C et al. MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. Am J Med Genet B Neuropsychiatr Genet 2007; 144B(4): 475-483.
201. Coutinho AM, Oliveira G, Morgadinho T, Fesel C, Macedo TR, Bento C et al. Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism. Mol Psychiatry 2004; 9(3): 264-271.
202. Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C et al. Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 2007; 121(2): 243-256.
203. Crepel A, Breckpot J, Fryns JP, De la Marche W, Steyaert J, Devriendt K et al. DISC1 duplication in two brothers with autism and mild mental retardation. Clin Genet 2010; 77(4): 389-394.

204. Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL et al. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 2008; 33(2): 353-360.

205. Crowe RR, Tsai LY, Murray JC, Patil SR, Quinn J. A study of autism using X chromosome DNA probes. Biol Psychiatry 1988; 24(4): 473-479.
206. Cukier HN, Rabionet R, Konidari I, Rayner-Evans MY, Baltos ML, Wright HH et al. Novel variants identified in methyl-CpG-binding domain genes in autistic individuals. Neurogenetics 2010; 11(3): 291-303.
207. Cukier HN, Skaar DA, Rayner-Evans MY, Konidari I, Whitehead PL, Jaworski JM et al. Identification of chromosome 7 inversion breakpoints in an autistic family narrows candidate region for autism susceptibility. Autism Res 2009; 2(5): 258-266.
208. Curran S, Powell J, Neale BM, Dworzynski K, Li T, Murphy D et al. An association analysis of candidate genes on chromosome 15 q11-13 and autism spectrum disorder. Mol Psychiatry 2006; 11(8): 709-713.
209. Curran S, Roberts S, Thomas S, Veltman M, Browne J, Medda E et al. An association analysis of microsatellite markers across the Prader-Willi/Angelman critical region on chromosome 15 (q11-13) and autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 137B(1): 25-28.

210. Cusco I, Medrano A, Gener B, Vilardell M, Gallastegui F, Villa O et al. Autism-specific copy number variants further implicate the phosphatidylinositol signaling pathway and the glutamatergic synapse in the etiology of the disorder. Hum Mol Genet 2009; 18(10): 1795-1804.

211. D'Adamo P, Bacchelli E, Blasi F, Lipp HP, Toniolo D, Maestrini E. DNA variants in the human RAB3A gene are not associated with autism. Genes Brain Behav 2004; 3(2): 123-124.
212. D'Amelio M, Ricci I, Sacco R, Liu X, D'Agruma L, Muscarella LA et al. Paraoxonase gene variants are associated with autism in North America, but not in Italy: possible regional specificity in gene-environment interactions. Mol Psychiatry 2005; 10(11): 1006-1016.
213. Daniels WW, Warren RP, Odell JD, Maciulis A, Burger RA, Warren WL et al. Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism. Neuropsychobiology 1995; 32(3): 120-123.
214. Daoud H, Bonnet-Brilhault F, Vedrine S, Demattei MV, Vourc'h P, Bayou N et al. Autism and nonsyndromic mental retardation associated with a de novo mutation in the NLGN4X gene promoter causing an increased expression level. Biol Psychiatry 2009; 66(10): 906-910.

215. Dauwerse JG, Ruivenkamp CA, Hansson K, Marijnissen GM, Peters DJ, Breuning MH et al. A complex chromosome 7q rearrangement identified in a patient with mental retardation, anxiety disorder, and autistic features. Am J Med Genet A 2010; 152A(2): 427-433.
216. Davis LK, Hazlett HC, Librant AL, Nopoulos P, Sheffield VC, Piven J et al. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am J Med Genet B Neuropsychiatr Genet 2008;


1   2   3   4   5   6   7   8   9   ...   12
:)


The database is protected by copyright ©hestories.info 2017
send message

    Main page

:)